1 tablet contains fosfotiamina 0.01, or 0.03 gram.
Of drugs
Complementary deficit vitamin B_1. Fosfauriliruetsa to become tiaminpirofosfat as a kofermenta involved in many reactions exchange.
Clinical pharmacology
Compared with tiaminom better deposited in the tissues of the body, to a lesser extent tiaminazoy destroyed, it is easier and quicker to become kocarboksilazu (tiaminpirofosfat), a bit less toxic.
Indications
Rapid, polinevrit (including non-B_1-vitaminna malnutrition), asthenic conditions. As an additional means, chronic circulatory insufficiency, chronic gastritis, accompanied by human movement and the secretion of stomach.